Nuvation Bio, Inc. (NUVB)
5.00
+0.05
(+1.01%)
USD |
NYSE |
Oct 09, 16:00
5.07
+0.07
(+1.40%)
After-Hours: 20:00
Nuvation Bio Cash and Short Term Investments (Quarterly) : 660.96M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 660.96M |
| March 31, 2026 | 533.73M |
| December 31, 2025 | 529.21M |
| September 30, 2025 | 549.04M |
| June 30, 2025 | 607.72M |
| March 31, 2025 | 461.68M |
| December 31, 2024 | 502.69M |
| September 30, 2024 | 549.14M |
| June 30, 2024 | 577.17M |
| March 31, 2024 | 596.98M |
| December 31, 2023 | 611.21M |
| September 30, 2023 | 619.34M |
| June 30, 2023 | 630.90M |
| Date | Value |
|---|---|
| March 31, 2023 | 646.61M |
| December 31, 2022 | 661.01M |
| September 30, 2022 | 673.94M |
| June 30, 2022 | 703.80M |
| March 31, 2022 | 737.70M |
| December 31, 2021 | 765.39M |
| September 30, 2021 | 791.78M |
| June 30, 2021 | 806.61M |
| March 31, 2021 | 824.71M |
| December 31, 2020 | 215.75M |
| September 30, 2020 | 1.345M |
| June 30, 2020 | 0.0034M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 11.07B |
| Johnson & Johnson | 20.76B |
| Pfizer Inc. | 11.70B |
| Eli Lilly & Co. | 8.95B |
| Merck & Co., Inc. | 7.182B |